---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-160339"
form_type: "8-K"
ticker: "PROK"
cik: "0001850270"
company_name: "PROKIDNEY CORP."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:41:51.204688+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ProKidney prices upsized $130M offering of 53.7M shares at $2.42 per share

## Summary
- Total offering of 53,719,009 shares at $2.42/share; net proceeds expected ~$136.7M.
- Public offering of 42,744,220 shares; underwriters have 30-day option for 6,411,633 more.
- Concurrent direct offering of 11,030,574 shares to certain investors; closings not contingent.
- Expected close June 13; proceeds for clinical trials, R&D, pre-commercial activities.
- Jefferies, J.P. Morgan, Guggenheim lead underwriting; PJT Partners as co-manager/adviser.

## SEC filing metadata
- accession: 0001193125-24-160339
- form_type: 8-K
- ticker: PROK
- cik: 0001850270
- company_name: PROKIDNEY CORP.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850270/000119312524160339/0001193125-24-160339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850270/000119312524160339/d814183d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-160339
- JSON: https://secwatch.observer/filing/0001193125-24-160339.json
- Plain text: https://secwatch.observer/filing/0001193125-24-160339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.